CURE
name pending profile ingest
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 10 | +3 | 89.30K | $10.02M | +4 | −1 |
| Q1 2026 | 7 | -2 | 21.17K | $1.94M | +1 | −3 |
| Q4 2025 | 9 | -1 | 87.06K | $9.71M | — | −1 |
| Q3 2025 | 2 | 0 | 6.18K | $516,026 | — | — |
| Q2 2025 | 1 | 0 | 21.67K | $1.71M | — | — |
| Q1 2025 | 1 | 0 | 9.22K | $983,264 | — | — |
| Q4 2024 | 1 | 0 | 9.61K | $886,815 | — | — |
| Q3 2024 | 1 | 0 | 1.07K | $142,902 | — | — |
| Q2 2024 | 1 | — | 39.83K | $4.65M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Citadel Advisors ✦ | 9.61K | +795.5% | $886,815 | 0.0% | ▲ Add | 3 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 15 holders, 51.16K shares, $4.66M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.